TALEN

TALEN1-leg1.1

ID

ZDB-TALEN-170921-1

Name

TALEN1-leg1.1

Previous Names

None

Target

leg1.1 (1)

Target Sequence 1

5' - CAACGCTACTAATGCCT - 3'

Target Sequence 2

5' - TGCTCCCCGGGGCCCAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
zju6	leg1.1
zju7	leg1.1

Expression

Gene expression in Wild Types + TALEN1-leg1.1

No data available

Phenotype

Phenotype resulting from TALEN1-leg1.1

No data available

Phenotype of all Fish created by or utilizing TALEN1-leg1.1

Phenotype	Fish	Conditions	Figures
whole organism decreased length, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 1 from Wang et al., 2021
whole organism decreased life span, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 8 from Hu et al., 2016
liver cell population proliferation process quality, abnormal	leg1.1^zju6/zju6	radiation	Fig. 3 from Hu et al., 2016
liver decreased size, abnormal	leg1.1^zju6/zju6	control	Fig. 2 from Hu et al., 2016
whole organism decreased thickness, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 1 from Wang et al., 2021
liver development process quality, abnormal	leg1.1^zju6/zju6	radiation	Fig. 3 from Hu et al., 2016
liver leg1.2 expression increased amount, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 1 from Wang et al., 2021
axis decreased length, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 8 from Hu et al., 2016
liver leg1.1 expression decreased amount, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 1 from Wang et al., 2021
liver decreased size, abnormal	leg1.1^zju6/zju6	overcrowding, heat exposure	Fig. 2 from Hu et al., 2016
whole organism leg1.2 expression increased amount, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 8 from Hu et al., 2016
whole organism leg1.2 expression increased amount, abnormal	leg1.1^zju6/zju6	standard conditions	Fig. 8 from Hu et al., 2016
liver lipid metabolic process disrupted, abnormal	leg1.1^zju6/zju6 (AB)	standard conditions	Fig. 2, Fig. 3 from Wang et al., 2025
liver lipid droplet increased amount, abnormal	leg1.1^zju6/zju6 (AB)	standard conditions	Fig. 3 from Wang et al., 2025
liver fatty, abnormal	leg1.1^zju6/zju6 (AB)	standard conditions	Fig. 2, Fig. 3 from Wang et al., 2025

Citations